AniClin Provides Pharmacokinetic Studies in Less than 5 Days
AniClin Preclinical Services (“AniClin”), specializing in in vivo services to support early drug development activities, is now offering complete pharmacokinetic (PK) studies in less than five days. This quick turnaround service comes after entering a strategic alliance with Taylor Technology, a subsidiary of PharmaNet Development Group, which specializes in supporting bioanalytical programs of any size from Discovery to Phase IV.
The PK package offers formulation, dosing, PK sampling, bioanalysis (plasma) of 6 timepoints, inclusive of quality control samples and front and back standard curves, all in less than 5 days. AniClin and Taylor Technology work seamlessly to meet this Fast PK timeline which involves the NCE arriving at AniClin where dosing is performed and plasma samples are collected. The samples are then delivered to Taylor Technology within two hours. The plasma samples are immediately processed upon receipt for development of non-GLP bioanalytical protocols, data analysis and estimation of PK parameters. The data and PK estimates are then emailed to the sponsor.
Telemedicine Considerations When Conducting Decentralized Clinical Trials
January 14th 2025Compliance with state telemedicine requirements is imperative, as not only will most clinical trial sponsors contractually require such compliance, but non-compliance may also subject the practitioner to licensure violations and liability.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
